Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Neximmune Inc

NEXI
Current price
0.25 USD -0.04 USD (-13.79%)
Last closed 0.21 USD
ISIN US65344D1090
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 308 222 USD
Yield for 12 month -91.07 %
1Y
3Y
5Y
10Y
15Y
NEXI
21.11.2021 - 28.11.2021

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Address: 9119 Gaither Road, Gaithersburg, MD, United States, 20877

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+2 120 558 USD

Current Year

-1 024 972 USD

Last Year

-1 495 345 USD

Current Quarter

Last Quarter

-114 912 USD

Key Figures NEXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 375 748 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -72.7 %
PEG Ratio
Return On Equity TTM -232.97 %
Wall Street Target Price 2 USD
Revenue TTM
Book Value 0.5 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -18.51 USD
Diluted Eps TTM -18.51 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NEXI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NEXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 19.10.2023
Dividend Date

Stock Valuation NEXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.5251
Price Book MRQ 0.335

Financials NEXI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NEXI

For 52 weeks

0.2 USD 21 USD
50 Day MA 0.34 USD
Shares Short Prior Month 16 621
200 Day MA 3.46 USD
Short Ratio 2.26
Shares Short 15 988
Short Percent 1.3 %